NEWARK, DE | The biomarker-based immunoassays market was valued at USD 5.4 billion in 2025 and is projected to reach USD 9.63 billion by 2036, expanding at a steady CAGR of 5.4%. This growth reflects a strategic shift in diagnostics toward precision quantitation of disease-specific biomarkers, enabling earlier intervention in high-mortality conditions such as oncology and neurology....

According to a comprehensive industry analysis by Future Market Insights (FMI), the global Clinical Drug Supply Chain Services Market is projected to experience robust growth over the next decade. Valued at USD 11.5 billion in 2026, the market is expected to expand at a CAGR of 7.6%, reaching a total valuation of USD 24.0 billion by 2036. The expansion...

NEWARK, DE | The Digital Pathology Market was valued at USD 11,817.9 million in 2026 and is projected to reach USD 38,036.8 million by 2036, expanding at a CAGR of 12.4% during the forecast period. According to Future Market Insights (FMI), this growth reflects a structural shift in pathology workflows, driven by slide digitisation, enterprise-scale deployments, and integration...

Immunoassays MarketReport The market research report on the Immunoassays Market industry provides crucial insights into current growth trends and primary revenue drivers from 2025 to 2034. It explores various elements impacting the Immunoassays Market, offering a thorough understanding of its dynamics. This report acts as a strategic tool for achieving business goals, featuring the...

The radiation-free fetal heart rate monitor market stood at USD 866.1 million in 2025. Future Market Insights projects the market will expand to USD 939.7 million in 2026 and reach USD 2,124.8 million by 2036, reflecting a steady compound annual growth rate (CAGR) of 8.5% over the forecast period. This structural expansion signals a broader transition toward connected, continuous...

The global Respiratory Inhaler Devices Market stands at USD 38.0 billion in 2026 and is forecasted to expand to USD 68.1 billion by 2036, reflecting a compound annual growth rate (CAGR) of 6.0%. This trajectory is fueled by the escalating prevalence of chronic respiratory conditions such as asthma and COPD, which continue to drive demand for effective inhalation therapies....

Vaginal Specula Market to Reach USD 1.6 Billion by 2036 Amid 3.7% CAGR   The global Vaginal Specula Market is projected to reach a valuation of USD 1.1 billion in 2026, expanding to USD 1.6 billion by 2036. This growth, representing a CAGR of 3.7%, is driven by non-discretionary gynecological examination volumes and the expansion of national cervical cancer screening programs....